OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Impact of COVID-19 Disease on Platelets and Coagulation
Geoffrey D. Wool, Jonathan Miller
Pathobiology (2020) Vol. 88, Iss. 1, pp. 15-27
Open Access | Times Cited: 511

Showing 1-25 of 511 citing articles:

Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin
Etheresia Pretorius, Maré Vlok, Chantelle Venter, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 400

D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19
Ayusha Poudel, Yashasa Poudel, Anurag Adhikari, et al.
PLoS ONE (2021) Vol. 16, Iss. 8, pp. e0256744-e0256744
Open Access | Times Cited: 209

A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
Douglas B. Kell, Gert Jacobus Laubscher, Etheresia Pretorius
Biochemical Journal (2022) Vol. 479, Iss. 4, pp. 537-559
Open Access | Times Cited: 209

Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects
Ma’mon M. Hatmal, Mohammad A. I. Al-Hatamleh, Amin N. Olaimat, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 556-556
Open Access | Times Cited: 197

Host genetic factors determining COVID-19 susceptibility and severity
Thirumalaisamy P. Velavan, Srinivas Reddy Pallerla, Jule Rüter, et al.
EBioMedicine (2021) Vol. 72, pp. 103629-103629
Open Access | Times Cited: 182

Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome
Maria Alice Freitas Queiroz, Pablo Fabiano Moura das Neves, Sandra Souza Lima, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 173

Complete blood count alterations in COVID-19 patients
Mariangela Palladino
Biochemia Medica (2021) Vol. 31, Iss. 3, pp. 403-415
Open Access | Times Cited: 124

Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects
Giuseppe Lisco, Anna De Tullio, Emilio Jirillo, et al.
Journal of Endocrinological Investigation (2021) Vol. 44, Iss. 9, pp. 1801-1814
Open Access | Times Cited: 100

COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19
Michele Costanzo, Marianna Caterino, Roberta Fedele, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2414-2414
Open Access | Times Cited: 67

Hematologic disorders associated with COVID-19: a review
Mandeep Singh Rahi, Vishal Jindal, Sandra-Patrucco Reyes, et al.
Annals of Hematology (2021) Vol. 100, Iss. 2, pp. 309-320
Open Access | Times Cited: 97

Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications
Adekunle Babajide Rowaiye, Okiemute Ajiroghene Okpalefe, Olukemi Onuh Adejoke, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 1487-1510
Open Access | Times Cited: 71

Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders
Roberta Giordo, Angelo Zinellu, Ali H. Eid, et al.
Molecules (2021) Vol. 26, Iss. 4, pp. 856-856
Open Access | Times Cited: 65

Potential relationships between COVID-19 and the thyroid gland: an update
Rania Naguib
Journal of International Medical Research (2022) Vol. 50, Iss. 2
Open Access | Times Cited: 58

An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility
Liuyang Wang, Thomas J. Balmat, Alejandro L. Antonia, et al.
Genome Medicine (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 56

A guide to molecular and functional investigations of platelets to bridge basic and clinical sciences
Tarun Tyagi, Kanika Jain, Sean X. Gu, et al.
Nature Cardiovascular Research (2022) Vol. 1, Iss. 3, pp. 223-237
Open Access | Times Cited: 54

Hematopoietic responses to SARS-CoV-2 infection
Shokrollah Elahi
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 51

S100A8/A9 drives the formation of procoagulant platelets through GPIbα
Martina Colicchia, Waltraud C. Schrottmaier, Gina Perrella, et al.
Blood (2022) Vol. 140, Iss. 24, pp. 2626-2643
Open Access | Times Cited: 47

SARS‐CoV‐2 and dengue virus co‐infection: Epidemiology, pathogenesis, diagnosis, treatment, and management
Chowdhury Nusaiba Binte Sayed Prapty, Raad Rahmat, Yusha Araf, et al.
Reviews in Medical Virology (2022) Vol. 33, Iss. 1
Open Access | Times Cited: 43

Gut microbiota-derived metabolites confer protection against SARS-CoV-2 infection
Julia A. Brown, Katherine Z. Sanidad, Serena Lucotti, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 38

Tissue factor in COVID-19-associated coagulopathy
Saravanan Subramaniam, Hema Kothari, Markus Bosmann
Thrombosis Research (2022) Vol. 220, pp. 35-47
Open Access | Times Cited: 37

Risk of Thrombosis during and after a SARS-CoV-2 Infection: Pathogenesis, Diagnostic Approach, and Management
Henry Sutanto, Gatot Soegiarto
Hematology Reports (2023) Vol. 15, Iss. 2, pp. 225-243
Open Access | Times Cited: 34

Platelet–Neutrophil Crosstalk in Thrombosis
Laura J. Mereweather, Adela Constantinescu‐Bercu, James T. B. Crawley, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1266-1266
Open Access | Times Cited: 29

Page 1 - Next Page

Scroll to top